1. A phase I, open label, clinical study to assess the safety and immunogenicity of indigenously developed liquid (DTwP-HepB-IPV-Hib) hexavalent combination vaccine in healthy toddlers aged 16–24 months. Issue 6 (30th November 2022) Authors: Sharma, Hitt; Lalwani, Sanjay; Parekh, Sameer; Pujari, Pramod; Shewale, Sunil; Palkar, Sonali; Hanumante, Neeta; Gokhale, Shilpa; Ks, Jaganathan; Kumar, Rakesh; Sharma, Inderjit; Gairola, Sunil Journal: Human vaccines & immunotherapeutics Issue: Volume 18:Issue 6(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A phase-I, open label clinical trial to assess the safety of Tdap vaccine manufactured by Serum Institute of India Pvt. Ltd. in adults. Issue 6 (5th February 2021) Authors: Sharma, Hitt; Anil, K.; Parekh, Sameer; Pujari, Pramod; Shewale, Sunil; Madhusudhan, R.L.; Patel, Jaya; Eswaraiah, Anand; Shaligram, Umesh; Gairola, Sunil; Rao, Harish Journal: Vaccine Issue: Volume 39:Issue 6(2021) Page Start: 882 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Safety and immunogenicity of an indigenously developed tetanus toxoid, diphtheria toxoid, and acellular pertussis vaccine (Tdap) in adults, adolescents, and children in India. (31st December 2023) Authors: Sharma, Hitt J; Parekh, Sameer; Pujari, Pramod; Shewale, Sunil; Desai, Shivani; Kawade, Anand; Ravi, Mandyam; Oswal, Jitendra; James, Saji; Mahantashetti, N.; Munshi, Renuka; Ghosh, Apurba; Rao, Venkateshwar; Balsubramaniam, Sundaram; Varughese, P.; Somshekhar, A.; Ginsburg, Amy Sarah; Rao, Haris... Journal: Expert review of vaccines Issue: Volume 22:Number 1(2023) Page Start: 278 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗